Bioinformatics and Artificial Intelligence in Vaccine Development
American Journal of Bioinformatics · 28.02.2022 · 3 (1) · 1-6
DOI: 10.71465/ajb.410 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Bioinformatics, online erschienen am 28.02.2022. Verfasst von Dr. Michael Roberts.
Abstract (Originalsprache)
The development of effective vaccines is a critical step in controlling infectious diseases, and the integration of bioinformatics and artificial intelligence (AI) has revolutionized this process. Bioinformatics tools help in the identification of potential vaccine targets, while AI-driven approaches enhance the design and optimization of vaccine candidates. This article explores how bioinformatics and AI are being utilized in vaccine development, from pathogen genomics and immune profiling to the design of vaccine candidates and prediction of immune responses. We also discuss the challenges and future directions of incorporating these technologies in vaccine research and development.
Zitieren
APA
Roberts, D. M. (2022). Bioinformatics and Artificial Intelligence in Vaccine Development. American Journal of Bioinformatics, 3(1), 1-6. https://doi.org/10.71465/ajb.410
Vancouver
Roberts DM. Bioinformatics and Artificial Intelligence in Vaccine Development. American Journal of Bioinformatics. 2022;3(1):1-6. doi:10.71465/ajb.410
BibTeX
@article{Roberts2022,
author = {Roberts, Dr. Michael},
title = {Bioinformatics and Artificial Intelligence in Vaccine Development},
journal = {American Journal of Bioinformatics},
year = {2022},
volume = {3},
number = {1},
pages = {1--6},
doi = {10.71465/ajb.410}
}
EUVIMED